Reuters logo
BRIEF-Oryzon Genomics FY net loss widens to 5.4 million euros vs year ago
February 24, 2017 / 5:25 PM / 10 months ago

BRIEF-Oryzon Genomics FY net loss widens to 5.4 million euros vs year ago

Feb 24 (Reuters) - Oryzon Genomics SA:

* FY net loss 5.4 million euros ($5.71 million) versus loss 992,000 euros year ago

* FY net sales 735,000 euros versus 4.3 million euros year ago

* FY research and development expenses at 5.2 million euros, of which 4.3 million euros correspond to development and 0.9 million euros to research Source text for Eikon: Further company coverage: ($1 = 0.9449 euros) (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below